Studies conducted in our laboratory led to the observation that alterations in lysosomal glycohydrolases (Gal, Hex, β-Galactosylcerebrosidase, CatB and Cathepsin S (CatS)) were detectable also in peripheral districts such as blood plasma and the Peripheral Blood Mononuclear Cells (PBMCs) of AD patients, and that some of these alterations could discriminate AD from MCI [232,233]. This evidence concerns the gene PIMREG and Alzheimer disease.